{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-296398","form_type":"8-K","ticker":"NUVB","cik":"0001811063","company_name":"Nuvation Bio Inc.","filed_at":"2026-07-06T21:15:46+00:00","discovered_at":"2026-07-06T21:18:00.259605+00:00","generated_at":"2026-07-06T21:18:03.618467+00:00","sec_items":["2.03","1.01","8.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Nuvation Bio completes full greenshoe, raising $287.5M in convertible notes","bullets":["Underwriters exercised full over-allotment for additional $37.5M of 0.75% Convertible Senior Notes due 2032.","Total aggregate principal amount of Notes sold: $287.5M; estimated net proceeds ~$277.6M.","Net proceeds used to pay $2.2M for additional capped call transactions; remainder for general corporate purposes.","Capped call transactions have cap price of $10.4580 per share, an 80% premium over June 25 closing price."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-296398","json":"https://secwatch.observer/filing/0001193125-26-296398.json","markdown":"https://secwatch.observer/filing/0001193125-26-296398.md","text":"https://secwatch.observer/filing/0001193125-26-296398.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1811063/000119312526296398/0001193125-26-296398-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1811063/000119312526296398/d136399d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-06T21:18:03.618467+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}